$3.56
-0.52-12.87%
Last update: Nov 6, 7:04 AM
Prelude Therapeutics Inc
PRLDNASDAQ
Prelude Therapeutics (PRLD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.18 | $-0.27 | $-0.24 | $-0.35 |
| Actual | $-0.14 | $-0.13 | $-0.20 | $-0.26 |
| Surprise | +22.2% | +51.8% | +16.7% | +25.7% |
| Revenue | ||||
| Estimate | — | — | $20.5M | — |
| Actual | $5.7M | $4.6M | $5.6M | $6.5M |
| Surprise | — | — | -72.5% | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.14 | $-0.15 | $-0.17 | $-0.16 |
| Revenue | ||||
| Consensus | $24.2M | $4.1M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.14 | $-0.18 | 22.2 % |
| Q1 | May 12, 2026 | $-0.13 | $-0.27 | 51.8 % |
| Q4 | Mar 10, 2026 | $-0.20 | $-0.24 | 16.7 % |
| Q3 | Nov 12, 2025 | $-0.26 | $-0.35 | 25.7 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Mar 10, 2026 | $5.64M | $20.50M | -72.5 % |
